Both angiotensin-receptor blockers (ARB) and angiotensin-converting enzyme inhibitors
(ACEI) have protective effects against atrial fibrillation (AF). The differences between ARB …

Objectives: This study was designed to identify all randomized clinical trial data evaluating
angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for the prevention …

Eur J Clin Invest 2011; 41 (7): 719–733 Abstract Background There is not a general
agreement regarding antiarrhythmic effects on atrial fibrillation (AF) of angiotensin …

Current evidence suggests that angiotensin‐converting enzyme inhibitors (ACEIs) and
angiotensin II receptor blockers (ARBs) have emerged as novel drugs for preventing the …

Aims To examine the associations between antihypertensive treatment with angiotensin-
converting enzyme inhibitors (ACEis) or angiotensin receptor blockers (ARBs), β-blockers …

The inhibition of the renin‐angiotensin system has demonstrated both experimental and
clinical effects in preventing atrial fibrillation. However, there is still uncertainty about the role …

We aimed to investigate the effectiveness and safety of angiotensin-converting enzyme
inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) on preventing atrial fibrillation …

Renin-angiotensin system (RAS) blockers have potential protective effects against atrial
fibrillation (AF). The purpose of this study was to determine if patient characteristics and …

Background Secondary analyses of clinical trial data suggest that, compared with other
agents, angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers …

The renin-angiotensin-aldosterone system (RAAS) has emerged as an important hormonal
system in the initiation and pathogenesis of atrial fibrillation (AF). Therefore, angiotensin …